Sawai Receives Approvals for Three Generic Drugs with Four Strengths

Feb. 15. 2024

Osaka, Japan – February 15, 2024 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Motohiko Kimura) received approvals by the Ministry of Health, Labour and Welfare for three generic drugs with four strengths. The one compound marked with an asterisk below is approved for the first time as generics.

The list of approved products

1. Zonisamide OD Tablets TRE

Generic name Zonisamide
Strengths OD Tablets: 25mg, 50mg
Brand products TRERIEF® OD Tablets 25mg, 50mg

2. Zinc Acetate Granules

Generic name Zinc Acetate Hydrate
Strengths Granules: 5%
Brand products NOBELZIN® Granules 5%

3. Sugammadex Intravenous Injection Syringes

Generic name Sugammadex Sodium*
Strengths Intravenous Injection Syringes: 200mg
Brand products BRIDION® Intravenous 200mg

The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.